roche__tree

Roche confirms over 200 job cuts at Irish facility

pharmafile | May 18, 2016 | News story | Manufacturing and Production |  Roche, clare, clarecastle, closure, irish site, job cuts, job losses 

Swiss pharmaceutical company Roche (VTX: ROG) has confirmed that 240 jobs are to go at their Irish site in Clare, which is set to close by 2019.

The company had originally announced its intention to leave the site late last year, but indicated that it would attempt to transfer the plant to a global pharma services company. These negotiations, however, were unsuccessful.

The facility in Clarecastle has been operational since 1974, and is Roche’s only operational presence in Ireland.

Advertisement

A company statement sad that all production at the site will “cease in a phased approach currently estimated to be completed between 2018 and 2019 when Roche will exit the site.”

The company will now enter into consultation with staff and their representatives going forward. The closure of the Irish site comes as Roche looks to focus its attention on a “new generation of specialised medicines”.

Sean Murray

Related Content

Roche secures CE Mark for automated latent tuberculosis blood test

Roche has received CE Mark approval for its Elecsys IGRA TB test, an automated blood …

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

Roche has expanded its global AI infrastructure with a NVIDIA AI factory, adding 2,176 high-performance …

alzheimers_brain

Roche receives CE Mark for blood test to help rule out Alzheimer’s

Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in …

The Gateway to Local Adoption Series

Latest content